ANTIPODES PARTNERS Ltd
Source: SEC Form 13F · as of Mar 2026ANTIPODES PARTNERS Ltd holds 17 biotech & pharma companies tracked by BioSniper, totaling $54.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$54.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ALNYLAM PHARMACEUTICALS, INC. (ALNY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALNYALNYLAM PHARMACEUTICALS, INC. | 145,310 | $48.1M |
| HUMAHumacyte Inc. | 5,723,750 | $3.5M |
| GPCRStructure Therapeutics Inc. | 45,361 | $2.2M |
| GILDGILEAD SCIENCES, INC. | 557 | $78K |
| REGNREGENERON PHARMACEUTICALS, INC. | 97 | $75K |
| TEVATeva Pharmaceutical Industries Limited | 2,234 | $67K |
| ARGXARGENX SE | 50 | $37K |
| TNGXTango Therapeutics, Inc. | 1,622 | $34K |
| DNTHDianthus Therapeutics, Inc. /DE/ | 364 | $31K |
| IRONDisc Medicine, Inc. | 476 | $30K |
| NUVLNuvalent, Inc. | 275 | $28K |
| ATAIAtai Beckley N.V. | 7,529 | $27K |
| TERNTerns Pharmaceuticals, Inc. | 455 | $24K |
| RLMDRELMADA THERAPEUTICS, INC. | 3,035 | $21K |
| VRDNViridian Therapeutics, Inc.\DE | 834 | $16K |
| ORICOric Pharmaceuticals, Inc. | 1,278 | $16K |
| BIOABioAge Labs, Inc. | 915 | $16K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.